Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma

Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: David Bond, MD
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05025800	ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma	active not recruiting	Phase 1 / Phase 2	47	M.D. Anderson Cancer CenterOTHER	1	Sep 18, 2026	clinicaltrials
NCT07714421	Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients	not yet recruiting	Phase 1	20	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 20, 2026